PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Chemische Eigenschaften,Einsatz,Produktion Methoden

S-S?tze Betriebsanweisung:

S22:Staub nicht einatmen.
S24/25:Berührung mit den Augen und der Haut vermeiden.

Verwenden

Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt has been used in cell culture for pharmaceutical inhibition and activation studies.

Allgemeine Beschreibung

Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt inhibits the protein kinase cAMP-activated catalytic subunit-α (PRKACA). The gene encoding it is localized on human chromosome 19p13.1.

Biochem/physiol Actions

Mutations in the gene encoding protein kinase cAMP-activated catalytic subunit-α (PRKACA) have been associated with Cushing′s syndrome.

PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Merck KGaA	--	ordercn@merckgroup.com	China	6394	58

---

• PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT
• C53H98N20O12C2HF3O2
• Serine/Threonine Kinase Inhibitors
• Cyclic Nucleotide Metabolism
• Cyclic Nucleotides and AnalogsSerine/Threonine Kinase Biology
• G Proteins and Cyclic Nucleotides
• Protein Kinase A (PKA)